Key result
Treatment with systemic antibiotics, intravenous steroids, and guideline-directed medical therapy led to symptomatic improvement in a 25-year-old female with ulcerative colitis-associated myopericarditis.
Why the study?
Myocarditis is a rare extraintestinal manifestation of inflammatory bowel disease that can stem from the disease process or treatments.
Case Report (n=1)
Myocarditis with cardiogenic shock can be a rare extraintestinal manifestation of an ulcerative colitis flare, which can be successfully managed with steroids and guideline-directed medical therapy for heart failure.
Suggests severe myopericarditis may be a rare extraintestinal manifestation of ulcerative colitis; leaves.
Myocarditis is a rare extraintestinal manifestation of inflammatory bowel disease. Myopericarditis-associated inflammatory bowel disease can be a side effect of the medications used to treat inflammatory bowel disease or the disease process. We present a 25-year-old female with history of ulcerative colitis presented with abdominal pain associated with sharp and central chest pain. She was in a flare of ulcerative colitis with bloody diarrhea. She developed shock and was in intensive care unit. Echocardiogram showed reduced ejection fraction and pericardial effusion. Coronary artery disease, sepsis, thyroid disease were ruled out. She was treated with systemic antibiotics, intravenous steroids, and guideline-directed medical therapy for presumed ulerative colitis associated with myopericarditis and had symptomatic improvement. Treatment of IBD-associated myopericarditis includes the standard induction treatment for IBD with steroids and guideline-directed medical therapy for heart failure.
No takes yet. Share an insight, caveat, or question.
Alyacoub et al. (2023) conducted a case report in Myocarditis with cardiogenic shock and severe ulcerative colitis flare (n=1). Systemic antibiotics, intravenous steroids, and guideline-directed medical therapy was evaluated on Symptomatic improvement. Treatment with systemic antibiotics, intravenous steroids, and guideline-directed medical therapy led to symptomatic improvement in a 25-year-old female with ulcerative colitis-associated myopericarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: